Clinical Trial Update: Efficacy and Safety of Baricitinib in Sjogren's Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating efficacy and safety of baricitinib in Sjogren's syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjogren Syndrome

Drugs mentioned

• Baricitinib (baricitinib)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Sjogren's Syndrome | Phase 2 | Status: COMPLETED